🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study

Recruitingn/aAges 4 Years - 14 YearsAllThe University of New South Wales
NCT06119243 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Currently, optical and pharmacological interventions have been developed to prevent the progression of childhood myopia. However, no myopia control strategy has been shown to have complete efficacy in controlling myopia progression in children. One possible reason is that risk factors contributing to the development of myopia were not controlled in previous clinical studies including time outdoors and near vision behaviour. This study aims to quantify time spent outdoors and near vision behavior in myopic children and its impact on myopia control efficacy. The outcomes of this study will guide clinicians on risk management and improve responses to existing treatments for progressive myopia.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Aged 6 to below 14 years old 2. Spherical equivalent myopic refractive error greater than -0.50 D 3. Best corrected logMAR visual acuity of 0.1 or better in each eye for 6- to 14-year-old children, and 0.2 logMAR or better than in each eye for 4 and 5-year-old children (adjusted for age-related expectations) 4. Good ocular and general health that would not preclude them from myopia control 5. Competent enough in English to fully understand the participant information and consent form 6. Willing to undergo treatment to slow myopia progression for one year Exclusion Criteria: 1. Strabismus at distance or near, or amblyopia 2. Systemic or ocular conditions that may affect contact lens use (e.g. severe allergy) or refractive development (e.g. ptosis) 3. Previous history of ocular surgery, trauma or chronic ocular disease that may affect their vision 4. Ocular or systemic medication use which may interfere or interact with myopia treatment or ocular development 5. Child, parents or guardians not willing to comply with treatment and/or follow-up schedule and planning to migrate or move during the one-year study duration
💊

What it tests

  • Vivior
📍

Where

5 sites
School of Optometry, University of California, Berkeley
Berkeley, United States
New England College of Optometry
Boston, United States
State University of New York (SUNY), College of Optometry
New York, United States
School of Optometry and Vision Science, UNSW
Sydney, Australia
Optometry and Vision Science, Queensland University of Technology
Kelvin Grove, Australia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy